Global Equity in CML
Low and Middle Income Countries
Reducing disparities in CML treatment, particularly in low- and middle-income countries (LMICs), lies at the heart of the iCMLf’s mission. These settings face significant challenges, including limited access to advanced diagnostics, molecular monitoring, and life-saving therapies such as TKIs, as well as fewer opportunities for clinicians to access up-to-date knowledge and training. In response, the iCMLf has developed targeted programs that help bridge gaps in knowledge, diagnostics, and treatment, strengthening clinical practice and improving outcomes for people living with CML.
"The iCMLf has given us knowledge, skills, and inspiration. Their updates and global discussions directly improve how we care for patients in Sudan."
- Dr. Abdelhakim Gaber - Addis Ababa University, Sudan
Programs for Low and Middle-Income Countires
iCMLf programs like the Clinical Preceptorships, Diagnosis and Testing Program, and Regional Discussion Groups provide innovative and collaborative solutions for LMICs. These initiatives connect international CML experts with clinicians in resource-limited settings, offering hands-on training, molecular diagnostic tools, and region-specific education. By fostering these partnerships, the iCMLf aims to ensure that patients in low and middle income countries receive equitable care, advancing its vision of a world where every person with CML has access to the best possible treatment.
"In every way, the iCMLf has improved physician education around the world. But the biggest impact of the iCMLf is the benefit to patients.Their initiatives not only provide access to treatment but also offer invaluable support, education, and research opportunities for physicians and patients alike.
"The iCMLf has shown that just a few people who are committed to the disease can impact the world."
- Dr Zeba Aziz - Hameed Latif Hospital, Pakistan
Resources for Low and Middle-Income Countries
Regional Discussion Groups
>View upcoming Regional Discussion Group meetings
>Watch past Regional Discussion Group sessions